ARROWHEAD PHARMACEUTICALS, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Pasadena, CA
SEC filing record 1 source field available
Fiscal year end
30 September
ARROWHEAD PHARMACEUTICALS, INC. has filed 1,338 SEC EDGAR filings since 02 Jan 1998

SEC filing history

Showing 901-925 of 995 matching filings.

Per page
25
Current page
37
UPLOAD

UPLOAD filing

Filing date
29 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
20 Dec 2011
Reporting date
20 Dec 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-178532

FORM S-3

Filing date
16 Dec 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
22 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-178073

FORM S-3

Filing date
21 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-178072

FORM S-3

Filing date
21 Nov 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
17 Nov 2011
Reporting date
17 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
15 Nov 2011
Reporting date
09 Nov 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
3

STOCK OPTION GRANT

Filing date
07 Nov 2011
Reporting date
26 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-48710

FORM SC13G

Filing date
28 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
27 Oct 2011
Reporting date
26 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
27 Oct 2011
Reporting date
24 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
26 Oct 2011
Reporting date
20 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
424B2 File 333-176159

FINAL PROSPECTUS SUPPLEMENT

Filing date
26 Oct 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION GRANT 10/2011

Filing date
24 Oct 2011
Reporting date
21 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STOCK OPTION GRANT 10/2011

Filing date
24 Oct 2011
Reporting date
21 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
24 Oct 2011
Reporting date
21 Oct 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
06 Oct 2011
Reporting date
30 Sep 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
EFFECT File 333-176159

EFFECT filing

Filing date
17 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

C. MCKENNEY OPTION GRANT 08/2011

Filing date
10 Aug 2011
Reporting date
08 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
10 Aug 2011
Reporting date
08 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
09 Aug 2011
Reporting date
08 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
S-3 File 333-176159

FORM S-3

Filing date
08 Aug 2011
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-21898

FORM 8-K

Filing date
08 Aug 2011
Reporting date
08 Aug 2011
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .